Navigation Links
The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
Date:6/22/2010

PITTSBURGH, June 22 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth programs to the region's life sciences enterprises, issued this statement through its President and Chief Executive Officer, John W. Manzetti regarding the PLSG's incubator company, Diamyd, signing an agreement with Ortho-McNeil-Janssen Pharmaceuticals, a Johnson & Johnson Company to commercialize a type-1 diabetes drug.

"Diamyd is a great example of a success story for the region and for the Pittsburgh Life Sciences Greenhouse model of taking technologies from Concept to Commercialization™," said John W. Manzetti, PLSG President & CEO. Mr. Manzetti continued, "Diamyd Inc., has  U.S. Research and Development headquarters in our incubator, and was formed from the merger of Pittsburgh's Nurel Therapeutics and Diamyd Medical in 2005. The PLSG has made direct investment in and supported the growth of this company and its commercialization efforts through our business growth programs since 2003. It is a pleasure to celebrate with them as they develop and commercialize their therapy and become a player in the global specialty pharma arena."

Darren Wolfe, CEO, Diamyd Inc., USA added, "We will utilize the support of the PLSG and the region's strengths as we build upon our global presence and commitment to the treatment and prevention of Diabetes." Dr. Wolfe continued, "We will continue to drive R&D from our lab in the PLSG incubator and are expecting to expand in the region."

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The Pittsburgh Life Sciences Greenhouse (PLSG) provides capital investments and customized company formation and business growth services to western Pennsylvania's life sciences enterprises. The PLSG supports biosciences companies with promising innovations in the following concentrations: Biotechnology Tools, Diagnostics, Healthcare IT, Medical Devices and Therapeutics. The PLSG is propelling the sustainable growth of the region's life sciences economy by accelerating research and technology commercialization with seed and early-stage companies; connecting investors with their Investment Portfolio companies; expanding established life sciences ventures and relocating biomedical companies to Pennsylvania. For more information, visit www.plsg.com.


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System
2. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
3. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
4. The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh
5. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
6. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
7. Kensey Nash to Present at the Jefferies 2010 Global Life Sciences Conference
8. Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference
9. Sequenom to Present at the Jefferies 2010 Global Life Sciences Conference
10. BioSpecifics Technologies Corp. to Present at Jefferies & Company 2010 Global Life Sciences Conference
11. Questcor to Present at the Jefferies 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... On Saturday, ... a treadmill relay – Miles by Moonlight to raise money for the American Heart ... or more. , Teams will work together to keep their treadmills moving for ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):